Aldurazyme and Claritin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Aldurazyme (laronidase) and Claritin (loratadine). Common drug interactions include nasopharyngitis among females and cardiac disorder among males.

The phase IV clinical study analyzes what interactions people have when they take Aldurazyme and Claritin. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Aldurazyme?

Aldurazyme has active ingredients of laronidase. eHealthMe is studying from 4,347 Aldurazyme users. Check the latest studies of Aldurazyme.

What is Claritin?

Claritin has active ingredients of loratadine. It is often used in allergies. eHealthMe is studying from 77,316 Claritin users. Check the latest studies of Claritin.



On Aug, 04, 2026

21 people who take Aldurazyme and Claritin together, and have interactions are studied.

Aldurazyme and Claritin drug interactions.

What are the common drug interactions of Aldurazyme and Claritin, by gender? *:

female:

  1. Nasopharyngitis (inflammation of the nasopharynx)
  2. Pyrexia (fever)
  3. Bone cyst
  4. Decreased appetite
  5. Dyspnoea (difficult or laboured respiration)
  6. Fluid overload (too much fluid in the blood)
  7. Infusion related reaction
  8. Maternal exposure during pregnancy (use of substance during pregnancy)
  9. Migraine (headache)
  10. Neck pain

male:

  1. Cardiac disorder
  2. Cardiac valve disease (heart valve disease)
  3. Joint stiffness
  4. Mastication disorder (disease of chewing food)
  5. Memory impairment
  6. Mobility decreased (ability to move is reduced)
  7. Pyrexia (fever)
  8. Rash
  9. Skin disorder (skin disease)
  10. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)

What are the common drug interactions of Aldurazyme and Claritin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Cardiac disorder
  2. Cardiac valve disease (heart valve disease)
  3. Dysphagia (a condition in which swallowing is difficult or painful)
  4. Dyspnoea (difficult or laboured respiration)
  5. Fatigue (feeling of tiredness)
  6. Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
  7. General physical health deterioration (weak health status)
  8. Joint stiffness
  9. Mastication disorder (disease of chewing food)
  10. Memory impairment

10-19:

  1. Acne (skin problems that cause pimples)
  2. Chest discomfort
  3. Hypersensitivity
  4. Increased appetite
  5. Infusion related reaction
  6. Lip swelling
  7. Musculoskeletal disorder (disease of the body's muscles, joints, tendons, ligaments and nerves)
  8. Urticaria (rash of round, red welts on the skin that itch intensely)
  9. Asthma
  10. Bone cyst

20-29:

n/a

30-39:

  1. Dyspnoea (difficult or laboured respiration)
  2. Infusion related reaction
  3. Maternal exposure during pregnancy (use of substance during pregnancy)
  4. Oxygen saturation decreased
  5. Placenta praevia haemorrhage (a condition that occurs during pregnancy when the placenta is abnormally placed, and partially or totally covers the cervix with bleeding)
  6. Pyrexia (fever)
  7. Wheezing (a high-pitched whistling sound made while you breath)

40-49:

  1. Spinal disorder (disease of spine a back bone)

50-59:

  1. Fluid overload (too much fluid in the blood)
  2. Pulmonary arterial hypertension (high blood pressure in the arteries of lungs)

60+:

n/a

What are the existing conditions these people have? *

  1. Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 3 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Aldurazyme and Claritin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Aldurazyme and Claritin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Aldurazyme:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Claritin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Aldurazyme and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Claritin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on laronidase and loratadine (the active ingredients of Aldurazyme and Claritin, respectively), and Aldurazyme and Claritin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: